Natural Ponds Remove Nitrogen More Effectively Than Stormwater Ponds, Researchers Find
Designed to control flooding, stormwater ponds are not as effective as natural ponds at removing nitrogen, a pollutant that can go downstream into lakes, rivers and other bodies of water, new University of Florida research shows.
What the Trained Eye Cannot See: Detecting Movement Defects in Early-Stage Parkinson’s Disease
A technique that uses videos and machine learning to quantify motor symptoms in early-stage Parkinson’s disease could help reveal signs of the disease and other movement disorders earlier, which could lead to better treatment outcomes.
Beer in Space: UF Researchers Study Microgravity’s Effect on Fermentation
A recently published study by University of Florida researchers provides insight into how beer yeast might behave when fermented in outer space.
Synthetic “Alien” DNA Provides Opportunities for Disease Diagnostics and Treatment
To help understand how DNA may have evolved on other planets, UF researcher Dr. Steven Benner and his partners synthesized DNA-like molecular systems with more than four nucleotides in the laboratory.
Atsena Therapeutics Receives Rare Pediatric Disease Designation From the U.S. FDA for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation (RPD) for ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Camera in Space to Capture the Impossible
Satlantis has been developing a camera to photograph the universe's dark matter -- which, by the way, is invisible.
First Type 1 Diabetes Patient Enrolled in Rise Therapeutics’ Latest Clinical Trial
Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, announced it has enrolled its first patient in its R-5280 placebo-controlled, blinded, Phase 1b type 1 diabetes clinical trial.
JPMorgan Upgrades Solid Biosciences Stock, Sees Growth Potential
JPMorgan upgraded Solid Biosciences stock, a biotechnology company that acquired UF startup AavantiBio, from Neutral to Overweight, and increased the price target to $15.00 from the previous $10.00. The firm's decision reflects a positive outlook on the company's prospects, particularly with upcoming developments expected in the fourth quarter.
RTI Surgical Has a New Chief Commercial Officer
UF startup RTI Surgical has appointed Chad Croasdale as chief commercial officer for his more than 20 years of commercial and financial experience in the medtech industry.
NIH Awards $2.8 Million to UF Researchers To Develop At-Home HIV Test Kit
A new, easy-to-use HIV-detection test kit being developed at the University of Florida using advanced CRISPR technology shows promise as an early-warning alarm system that could save millions of lives.
